Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122784962 | 12278496 | 2 | F | 20160226 | 20160810 | 20160418 | 20160817 | EXP | GB-MHRA-EYC 00136338 | GB-PFIZER INC-2016159572 | PFIZER | 73.00 | YR | F | Y | 92.00000 | KG | 20160817 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122784962 | 12278496 | 1 | PS | LINEZOLID. | LINEZOLID | 1 | UNK | 21131 | |||||||||||
| 122784962 | 12278496 | 2 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | UNK | Y | 62911 | POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
| 122784962 | 12278496 | 3 | SS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 1 G, 3X/DAY | Y | 90940 | 1 | G | TID | ||||||
| 122784962 | 12278496 | 4 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 77245 | SOLUTION FOR INJECTION | ||||||||||
| 122784962 | 12278496 | 5 | SS | RIFAMPICIN | RIFAMPIN | 1 | UNK | Y | 0 | ||||||||||
| 122784962 | 12278496 | 6 | C | CO-DYDRAMOL | ACETAMINOPHENDIHYDROCODEINE | 1 | 10/500: 1-2 FOUR TIMES A DAY WHEN REQUIRED | 0 | |||||||||||
| 122784962 | 12278496 | 7 | C | EMULSIDERM | 2 | UNK | 0 | ||||||||||||
| 122784962 | 12278496 | 8 | C | ETANERCEPT | ETANERCEPT | 1 | 1 DF, WEEKLY | 0 | 1 | DF | /wk | ||||||||
| 122784962 | 12278496 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | AT 40MG ONCE A DAY (MORNING) | 0 | 40 | MG | QD | ||||||||
| 122784962 | 12278496 | 10 | C | IRBESARTAN. | IRBESARTAN | 1 | 300MG ONCE A DAY (MORNING) | 0 | 300 | MG | QD | ||||||||
| 122784962 | 12278496 | 11 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 125 UG, 1X/DAY | 0 | 125 | UG | QD | ||||||||
| 122784962 | 12278496 | 12 | C | VERAPAMIL HYDROCHLORIDE. | VERAPAMIL HYDROCHLORIDE | 1 | 120 MG, 2X/DAY | 0 | 120 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122784962 | 12278496 | 3 | Infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122784962 | 12278496 | OT |
| 122784962 | 12278496 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122784962 | 12278496 | Acute kidney injury | |
| 122784962 | 12278496 | C-reactive protein increased | |
| 122784962 | 12278496 | Drug eruption | |
| 122784962 | 12278496 | Exfoliative rash | |
| 122784962 | 12278496 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122784962 | 12278496 | 2 | 20160226 | 0 | ||
| 122784962 | 12278496 | 3 | 20160220 | 20160226 | 0 |